We are live on ! Find out more
MRVI icon

Maravai LifeSciences

229 hedge funds and large institutions have $5.36B invested in Maravai LifeSciences in 2021 Q4 according to their latest regulatory filings, with 56 funds opening new positions, 89 increasing their positions, 60 reducing their positions, and 53 closing their positions.

New
Increased
Maintained
Reduced
Closed

151% more call options, than puts

Call options by funds: $11.4M | Put options by funds: $4.57M

48% more repeat investments, than reductions

Existing positions increased: 89 | Existing positions reduced: 60

6% more first-time investments, than exits

New positions opened: 56 | Existing positions closed: 53

0% more funds holding

Funds holding: 228229 (+1)

14.26% less ownership

Funds ownership: 111.7%97.44% (-14%)

14% less capital invested

Capital invested by funds: $6.27B → $5.36B (-$907M)

50% less funds holding in top 10

Funds holding in top 10: 42 (-2)

Holders
229
Holders Change
+1
Holders Change %
+0.44%
% of All Funds
3.52%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
56
Increased
89
Reduced
60
Closed
53
Calls
$11.4M
Puts
$4.57M
Net Calls
+$6.87M
Net Calls Change
+$11.7M
Name Holding Trade Value Shares
Change
Change in
Stake
State Board of Administration of Florida Retirement System
76
State Board of Administration of Florida Retirement System
Florida
$3.49M +$1.33M +32,840 +65%
Jane Street
77
Jane Street
New York
$3.48M +$3.36M +82,973 New
FAM
78
Fred Alger Management
New York
$3.45M -$122K -3,020 -4%
TD Asset Management
79
TD Asset Management
Ontario, Canada
$3.41M
State of New Jersey Common Pension Fund D
80
State of New Jersey Common Pension Fund D
New Jersey
$3.16M +$634K +15,658 +26%
PMAM
81
Picton Mahoney Asset Management
Ontario, Canada
$3.02M +$637K +15,720 +28%
SSA
82
Schonfeld Strategic Advisors
New York
$2.89M +$2.26M +55,904 +430%
Schroder Investment Management Group
83
Schroder Investment Management Group
United Kingdom
$2.83M +$2.03M +50,221 +290%
JF
84
Jump Financial
Illinois
$2.79M +$297K +7,341 +12%
B
85
Bailard
California
$2.77M +$40.7K +1,004 +2%
Squarepoint
86
Squarepoint
New York
$2.56M +$2.48M +61,153 New
SRC
87
Stone Run Capital
New York
$2.47M +$2.38M +58,785 New
Ohio Public Employees Retirement System (OPERS)
88
Ohio Public Employees Retirement System (OPERS)
Ohio
$2.47M +$93.9K +2,318 +4%
Allianz Asset Management
89
Allianz Asset Management
Germany
$2.44M +$901K +22,241 +62%
PPA
90
Parametric Portfolio Associates
Washington
$2.33M -$618K -15,265 -22%
VOYA Investment Management
91
VOYA Investment Management
Georgia
$2.28M +$882K +21,769 +67%
Los Angeles Capital Management
92
Los Angeles Capital Management
California
$2.01M +$485K +11,974 +33%
BHWA
93
Beacon Harbor Wealth Advisors
Virginia
$1.9M +$1.84M +45,364 New
DekaBank Deutsche Girozentrale
94
DekaBank Deutsche Girozentrale
Germany
$1.88M +$1.85M +45,617 +6,621%
RC
95
Renaissance Capital
Connecticut
$1.88M -$159K -3,921 -8%
DCM
96
Dupont Capital Management
Delaware
$1.76M +$1.62M +40,113 +2,161%
Treasurer of the State of North Carolina
97
Treasurer of the State of North Carolina
North Carolina
$1.67M +$130K +3,210 +9%
GH
98
GAM Holding
Switzerland
$1.67M +$220K +5,420 +16%
MWVC
99
Morgens Waterfall Vintiadis & Co
New York
$1.59M +$1.54M +38,000 New
TCM
100
Tributary Capital Management
Nebraska
$1.5M -$203K -5,000 -12%

MRVI Hedge Fund Activity: Q4 2021 in Review

229 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Maravai LifeSciences (MRVI) for Q4 2021, worth a combined $5.36B — down 14% from $6.27B a quarter earlier.

Buyers outnumbered sellers: 56 funds opened new MRVI positions and 53 closed out — a net gain of 3 holders — while 89 added to existing stakes and 60 trimmed.

The largest buyer was Select Equity Group, adding an estimated $341M. The largest seller was Fidelity Investments, cutting an estimated $210M.

  • 229 institutional investors held Maravai LifeSciences (MRVI) as of Q4 2021, up from 228 in Q3 2021.
  • Funds reported $5.36B of Maravai LifeSciences stock for Q4 2021, down 14% quarter-over-quarter.
  • 56 funds opened new Maravai LifeSciences positions in Q4 2021 and 53 closed out, a net change of +3 holders.
  • The largest Maravai LifeSciences buyer in Q4 2021 was Select Equity Group, an estimated $341M added.
  • The largest Maravai LifeSciences seller in Q4 2021 was Fidelity Investments, an estimated $210M sold.

Based on aggregated 13F filings for Q4 2021.